About HEMA Diagnostic Systems
HEMA Diagnostic Systems is a Healthcare company based in Miramar (United States) founded in 2000, and was acquired by Generex Biotechnology in December 2018. IVDs for infectious diseases in developing nations are developed. HEMA Diagnostic Systems offers products and services including Hema Express Platform, Cassette Test Kit, Dipstick Test Kit, Hema EZ Platform, and QuantiFlexx ELISA Test. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Diversified. Its competitors include Inflammatix, Karius and Visby Medical; 3 of its 3 listed competitors have raised funding.
Company details
Hema Diagnostic Systems (HDS) manufactures and distributes high quality, reliable in-vitro diagnostic tests that address the global medical communitys needs for simple, accurate, fast, and affordable rapid diagnostic tests for HIVAIDS, tuberculosis, malaria and other infectious diseases. HDS offers unique proprietary and patented delivery systems incorporating quality test strips, principally manufactured under GMP conditions in the United States, creating a system of rapid diagnostic assays. HDS rapid HIV assays have been evaluated and approved by the Centers for Disease Control (CDC) and are included on the USAID Blanket Waiver List. This enables organizations around the globe to procure the tests with funds under the PEPFAR Program (The Presidents Emergency Program for AIDS Relief).
- Headquarters Miramar, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website rapid123.com
- Social LinkedIn
- Acquired by Generex Biotechnology (Dec 2018)
- Investors
- Acquired byGenerex Biotechnology
(Dec 2018)
Products & Services of HEMA Diagnostic Systems
HEMA Diagnostic Systems offers a comprehensive portfolio of products and services, including Hema Express Platform, Cassette Test Kit, Dipstick Test Kit, Hema EZ Platform, and QuantiFlexx ELISA Test.
Platform for rapid infectious disease testing
Kit for point-of-care infectious disease detection
Simple kit for diagnosing infectious diseases
Platform for easy infectious disease assays
Test for quantitative infectious disease analysis
Investors in HEMA Diagnostic Systems
HEMA Diagnostic Systems has secured backing from 1 investor. Prominent investors backing the company include Generex Biotechnology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Technologies for large molecule drug delivery are developed. | 1983 | generex.com | Miramar, United States |
Investor details for HEMA Diagnostic Systems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of HEMA Diagnostic Systems
2 dated milestones of HEMA Diagnostic Systems across 18 years, from founding to its latest funding, stage changes and deals.
- Founded HEMA Diagnostic Systems is founded.
- Exit Acquired by Generex Biotechnology.
Competitors of HEMA Diagnostic Systems
HEMA Diagnostic Systems has 3 listed competitors in our database, 3 of them funded. They include Inflammatix, Karius and Visby Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inflammatix.com | 2016 | San Francisco, United States | $191.47M | 54 | Provider of diagnostic solutions for systemic infections | |
| kariusdx.com | 2014 | Redwood, United States | $315M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | |
| visbymedical.com | 2010 | San Jose, United States | $386.33M | 251 | Portable PCR diagnostics for infectious diseases are developed. |
Detailed competitors of HEMA Diagnostic Systems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of HEMA Diagnostic Systems
Websites that share an audience with HEMA Diagnostic Systems (rapid123.com).
Websites whose visitors overlap most with HEMA Diagnostic Systems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bprc.nl | 100% | 3.1K | #5,741,917 | View details | |
theaasm.org | theaasm.org | 100% | – | ||
demoplanet.free.fr | demoplanet.free.fr | 62% | – |
Top companies in Infectious Diseases
3 companies that operate in the same segment as HEMA Diagnostic Systems (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hema Diagnostic Systems
Complete news archive for HEMA Diagnostic Systems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HEMA Diagnostic Systems
HEMA Diagnostic Systems was founded in 2000.
HEMA Diagnostic Systems is headquartered in Miramar, United States. It is registered at Miramar, Florida, United States.
Hema Diagnostic Systems (HDS) manufactures and distributes high quality, reliable in-vitro diagnostic tests that address the global medical communitys needs for simple, accurate, fast, and affordable rapid diagnostic tests for HIVAIDS, tuberculosis, malaria and other infectious diseases. HDS offers unique proprietary and patented delivery systems incorporating quality test strips, principally manufactured under GMP conditions in the United States, creating a system of rapid diagnostic assays. HDS rapid HIV assays have been evaluated and approved by the Centers for Disease Control (CDC) and are included on the USAID Blanket Waiver List. This enables organizations around the globe to procure the tests with funds under the PEPFAR Program (The Presidents Emergency Program for AIDS Relief).
HEMA Diagnostic Systems's top competitors include Visby Medical, Inflammatix and Karius.
HEMA Diagnostic Systems offers Hema Express Platform, Cassette Test Kit, Dipstick Test Kit, Hema EZ Platform, and QuantiFlexx ELISA Test.
HEMA Diagnostic Systems has 1 investor. Key investors include Generex Biotechnology.
Yes. HEMA Diagnostic Systems was acquired by Generex Biotechnology in December 2018.